Grindr (GRND) Earnings Date & Reports

Key Takeaways

• Grindr reported third-quarter 2026 revenue of $141.4 million, up 22% year over year and above the consensus estimate of roughly $135.8 million.
• Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) rose to $61.7 million, a 43.7% margin, compared with $54.8 million a year earlier.
• The company posted a net loss of $6.6 million, driven largely by transaction-related costs tied to its acquisition of PurposeMed (Freddie) and a non-cash derivative fair-value charge.
• Management raised its full-year 2026 outlook to revenue of at least $560 million and Adjusted EBITDA of at least $236 million.
• Grindr also introduced initial 2027 guidance calling for revenue of at least $705 million and Adjusted EBITDA of at least $275 million.
• For more detail on this ticker, visit the dedicated pages for Major News, Today's Price Move, Price Targets, and Forecast.
• Explore Trending AI Robots to discover AI-powered trading strategies currently drawing investor attention.

Earnings Context and Why It Matters

Grindr's third-quarter report matters because it tests whether the company can sustain its rapid, high-margin growth while absorbing the largest strategic moves in its recent history. The quarter closed just before Grindr completed its acquisition of PurposeMed (Freddie) on November 2, 2026, a deal that adds healthcare services to the company's core social networking and subscription business. Investors were watching for continued monetization strength, durable paying-user growth, and any signals about how new initiatives such as the Edge AI premium tier are progressing. Because Grindr combines double-digit revenue growth with unusually strong cash generation, each earnings release also provides a read on operating leverage, margin durability, and the balance between reinvestment and shareholder returns.

Reported Results

For the third quarter ended September 30, 2026, Grindr reported revenue of $141.4 million, a 22% increase from $115.8 million in the prior-year period. The result exceeded the consensus estimate of approximately $135.8 million.

Adjusted EBITDA reached $61.7 million, up from $54.8 million a year earlier, representing a margin of 43.7%. The company posted a net loss of $6.6 million for the quarter, compared with net income of $30.8 million in the same period last year. Grindr attributed the swing primarily to transaction-related costs associated with the PurposeMed acquisition, which closed on November 2, 2026, as well as a non-cash charge from the change in fair value of a derivative embedded in forward repurchase transactions.

Alongside the results, management raised its full-year 2026 guidance. The company now expects revenue of at least $560 million, up from a prior outlook of approximately $540 million, and Adjusted EBITDA of at least $236 million, up from approximately $232 million. Grindr also provided an initial 2027 outlook for revenue of at least $705 million and Adjusted EBITDA of at least $275 million.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking names like Grindr and its peers, the AI Screener can provide a faster way to surface relevant setups and monitor shifting market conditions.

Market Reaction and Investor Sentiment

The market's focus around this report centered on two competing forces: a stronger-than-expected top line and raised guidance, offset by a headline net loss and the integration costs of a major acquisition. Investors generally looked past the quarterly loss because it was driven by identifiable, largely non-recurring items tied to the Freddie transaction and derivative accounting, rather than weakening core operations. The raised 2026 guidance and a concrete 2027 revenue framework provided forward visibility that supported a constructive tone. Still, sentiment carries a measure of caution: the acquisition of Freddie introduces new operational complexity and upfront scaling costs, and management has signaled that advertising growth is expected to moderate in the coming year.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors will be tracking several themes. First, guidance execution: management now expects at least $560 million in 2026 revenue and at least $236 million in Adjusted EBITDA, with the Freddie acquisition contributing only negligibly in the fourth quarter following its close. Second, the company's initial 2027 outlook of at least $705 million in revenue and at least $275 million in Adjusted EBITDA implies roughly 26% top-line growth and a margin of about 39% or better.

A key catalyst to watch is the Edge AI premium tier, which management has described as a significant long-term revenue opportunity but has not yet fully incorporated into near-term guidance. The Freddie integration will also be closely monitored, including the pace of investment in clinical and pharmacy infrastructure and whether the business proves accretive to consolidated EBITDA (earnings before interest, taxes, depreciation, and amortization) dollars.

Finally, investors should track monetization metrics such as paying users and average revenue per paying user, the trajectory of advertising revenue, and how pricing changes for the XTRA and Unlimited tiers affect conversion and churn. Balance-sheet developments, including the structured share repurchase program and any further capital-return decisions, round out the areas likely to shape the narrative in coming quarters.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations